Article
Pharmacological rescue of follicle-stimulating hormone receptor mutants. In vitro and in silico studies.
Endocrinology - 7 Apr 2026
Zariñán Teresa, Jardón-Valadez Eduardo, Gutiérrez-Sagal Rubén, Ulloa-Pérez Ernesto, Nataraja Selvaraj, Yu Henry N, Ulloa-Aguirre Alfredo
Abstract excerpt
Mutations in the follicle-stimulating hormone receptor (FSHR) may result in impaired plasma membrane expression due to misfolding and intracellular retention of the receptor, leading to disease. Rescue of misfolded receptors may be achieved employing pharmacological chaperones (small molecules that specifically bind misfolded proteins, promoting their correct trafficking to their site of action). This study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
